Aseptuva is a MedTech startup based in Technopark Winterthur, Switzerland. Our team comprises of 3 co-founders with diverse skill sets, who innovate new solutions to tackle healthcare challenges.
Our advisory board consists of serial entrepreneurs, healthcare & regulatory experts and patent strategists.
With the support of Innosuisse and our research partner ZHAW Wädenswil we established the Proof-of-Concept of our technology.
Aseptuva's international patent strategy encompasses the key technology for several medical devices and applications. Patents awaiting approval.
Aseptuva's prototype immediately aims for implementation in pre-clinical and clinical studies.
Several Letters of Intent (LOI) have been obtained from renowned healthcare experts and Intensive Care Unit directors in Switzerland and abroad.